Virginia A. Carroll

FDA investigator

Appears on 5 documents from 2018 to 2022, most often at sites in California. Most often cites control of microbiological contamination (21 CFR 211.113).

5
Documents on file
6.0
Observations per 483
2018
First seen
2022
Most recent

What they cite most

From 30 observations

Activity by year

2018: 1, 2019: 2, 2020: 1, 2022: 1

Where

California 2 · Germany 1 · Japan 1 · South Korea 1

Is Virginia A. Carroll coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 Revance Therapeutics, Inc.Jul 15, 2022 · Newark, California
483 TERUMO YAMAGUCHI CORPORATIONFeb 19, 2020 · SAYAMA, Japan
483 PCI San Diego, Inc.Dec 20, 2019 · San Diego, California
483 Baxter Oncology GmbHNov 5, 2019 · Halle/Westfalen, Germany
483 Samsung Biologics Co., Ltd.May 11, 2018 · Incheon, South Korea

About this profile

What does Virginia A. Carroll inspect?

Virginia A. Carroll appears on 5 documents on file covering 5 sites, most often in California.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.67 and 21 CFR 211.100.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Virginia A. Carroll is dated Jul 15, 2022.